lansoprazole has been researched along with Torsade de Pointes in 3 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazzerini, PE | 1 |
| Bertolozzi, I | 1 |
| Rossi, M | 1 |
| Capecchi, PL | 1 |
| Laghi-Pasini, F | 1 |
| Lorberbaum, T | 1 |
| Tatonetti, NP | 1 |
| Asajima, H | 1 |
| Saito, N | 1 |
| Ohmura, Y | 1 |
| Ohmura, K | 1 |
3 other studies available for lansoprazole and Torsade de Pointes
| Article | Year |
|---|---|
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
Topics: Ceftriaxone; Data Mining; Drug Interactions; Electrocardiography; Humans; Lansoprazole; Long QT Synd | 2017 |
Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
Topics: Ceftriaxone; Electrocardiography; Humans; Lansoprazole; Long QT Syndrome; Torsades de Pointes | 2017 |
Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Arrhythmia Agents; Anti-Ulcer Agents; Disopyrami | 2012 |